Literature DB >> 16755149

Current status of antihypertensive prescription and associated blood pressure control in Japan.

Hisao Mori1, Hiroshi Ukai, Hareaki Yamamoto, Saburo Saitou, Kouich Hirao, Mikio Yamauchi, Satoshi Umemura.   

Abstract

The importance of tight blood pressure (BP) control has been established. We performed cross-sectional studies on the current status of BP control and the prescription and efficacy of antihypertensive drugs in hypertensive patients in Japan. The data were also evaluated in subgroups with or without diabetes mellitus (DM) and in winter and summer. Analyses were performed on the collected data of 12,437 treated hypertensive patients in winter and 5,972 in summer 2002. In winter, 50.3% of patients received calcium channel blockers (CCBs), 15.3% received angiotensin converting enzyme inhibitors (ACEIs) and 11.0% received angiotensin receptor blockers (ARBs). In the patients receiving monotherapy, 69% of patients received a CCB, 13% an ACEI and 11.0% an ARB. A total of 2,918 patients received combination therapy, and CCBs were the most frequently (89.6%) prescribed component of such therapy. Prescriptions of beta-blockers (BBs) decreased and those of CCBs and diuretics (D) increased with age (p<0.001). The rate of patients with adequately controlled BP less than 140/90 mmHg was 40.3% in the CCB group, 37.6% in the D group, and 36.9% in the BB group (p<0.001). In patients receiving combination therapy, those with CCB+D had the best rate of BP control (40.7%). The rate of patients with adequately controlled BP was lower in winter than in summer at both a target BP of 140/90 mmHg (36.2% vs. 43.8%, p<0.001) and a target BP of 130/85 mmHg in patients younger than 60 years old (15.5% vs. 18.6%, p<0.02). In diabetic patients, the target BP (130/80 mmHg) was achieved in only 11.3%, which was lower (p<0.05) than the rate in non-diabetic patients (13.1%). In conclusion, the present cross-sectional study showed that CCBs were the most frequently prescribed agent for the treatment of hypertension in Japan. The rate of adequate BP control was less than 50% and was even worse in patients with DM and in winter. Our results indicate that physicians should treat hypertension more intensively to achieve the target BP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755149     DOI: 10.1291/hypres.29.143

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  31 in total

1.  Pharmacogenomics of antihypertensive drugs: past, present and future.

Authors:  Julie A Johnson
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

2.  Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.

Authors:  Hiromi Rakugi; Takuya Tsuchihashi; Kazuyuki Shimada; Hirotaka Numaguchi; Chisato Nishida; Hiroya Yamaguchi; Masayoshi Shirakawa; Kyoichi Azuma; Kenji P Fujita
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

3.  Diagnosis and Control of Hypertension in the Elderly Populations of Japan and the United States.

Authors:  Yasuhiko Saito; Shieva Davarian; Atsuhiko Takahashi; Edward Schneider; Eileen M Crimmins
Journal:  Int J Popul Stud       Date:  2015-12-31

Review 4.  Advancing management of hypertension through pharmacogenomics.

Authors:  Julie A Johnson
Journal:  Ann Med       Date:  2012-06       Impact factor: 4.709

5.  Understanding the decline of mean systolic blood pressure in Japan: an analysis of pooled data from the National Nutrition Survey, 1986-2002.

Authors:  Nayu Ikeda; Emmanuela Gakidou; Toshihiko Hasegawa; Christopher J L Murray
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

6.  Sociodemographic correlates of four indices of blood pressure and hypertension among older persons in Japan.

Authors:  Shieva Davarian; Eileen Crimmins; Atsuhiko Takahashi; Yasuhiko Saito
Journal:  Gerontology       Date:  2013-05-15       Impact factor: 5.140

7.  Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.

Authors:  Izel F Sørensen; Ana I Vazquez; Marguerite R Irvin; Peter Sørensen; Barry R Davis; Charles E Ford; Eric Boerwinkle; John H Eckfeldt; Donna K Arnett
Journal:  Pharmacogenet Genomics       Date:  2014-11       Impact factor: 2.089

8.  Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.

Authors:  Kenji Oki; Kiminori Yamane; Shuhei Nakanishi; Reiko Nakashima; Kuniaki Jitsuiki; Nobuoki Kohno
Journal:  Endocrine       Date:  2009-10-08       Impact factor: 3.633

9.  Relationship between outpatient visit frequency and hypertension control: a 9-year occupational cohort study.

Authors:  Azusa Shima; Yukako Tatsumi; Tatsuro Ishizaki; Kayo Godai; Yuichiro Kawatsu; Tomonori Okamura; Tomofumi Nishikawa; Akiko Morimoto; Ayumi Morino; Naomi Miyamatsu
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

Review 10.  Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients.

Authors:  Satoshi Hoshide; Kazuomi Kario; Naoko Tomitani; Tomoyuki Kabutoya; Yook-Chin Chia; Sungha Park; Jinho Shin; Yuda Turana; Jam Chin Tay; Peera Buranakitjaroen; Chen-Huan Chen; Jennifer Nailes; Huynh Van Minh; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Boon Wee Teo; Narsingh Verma; Yuqing Zhang; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.